Pharmaceutical
ChemLinked
Market
Chemical
Food
Cosmetic
Pharmaceutical
Japan
Agrochemical
Sustainability
LOG IN
SIGN UP
LOG IN
Home
News
Insights
Database
Events
Webinars
Offline Events
Services
Home
News
Insights
Database
Regulatory Database
Drug Catalog
ChP Standards
Events
Webinars
Offline Events
Services
Search
News
Comprehensive coverage on the latest pharmaceutical regulatory update and industry activities in China.
All
Regulation
Policy
Industry
Pipeline
All
Regulation
Policy
Industry
Pipeline
Topic
Domain
Regulation
Guideline
Law & Regulation
Pharmacopoeia
Reference Listed Drug (RLD)
Hot topic
Bioequivalence (BE)
Clinical Trial
CMC
CRO
DMF
Drug Registration
E-commerce
GCP
GLP
GMP
GSP
License in/out
MAH
Marketing Approval
New Drug
Patent
Pharmacovigilance
Post-market
Priority Review
Real World Data
Policy
Health Insurance
NRDL
Volume-based Procurement
Product
API
Biological Product
Biosimilar
Excipient
Generic Drug
Innovative Drug
Medical Device
OTC Drug
Packaging
Pediatric Drug
Vaccine
Apply
Cancel
Cancer
Cardiovascular Disease
Cell Therapy
COVID-19
Diabetes
Gene Therapy
Rare Disease
Respiratory Disease
Apply
Cancel
New Drug
INDUSTRY
Marketing Approval
Priority Review
Drug Registration
New Drug
Monthly Report: New Drug Approvals in China | May 2021
In May 2021, China NMPA granted approvals to a total of nine innovative new drugs, improved new drugs, imported original drugs and first generics.
Jun 15, 2021
INDUSTRY
Marketing Approval
Priority Review
Drug Registration
New Drug
Monthly Report: New Drug Approvals in China | April 2021
In Apr. 2021, China NMPA approved a total of 12 new drugs. Eight of them are therapeutic biological products and the other four are chemical drugs.
May 14, 2021
Pre
1
...
3
4
5
6
7
Most Popular
[Updated] Pharma Licensing Deals Involving Chinese Companies in 2023
[Updated] Top 10 CROs With the Highest Revenues in 2023
Decoding China's Good Pharmacovigilance Practices (GVP)
2023 China CDE Drug Evaluation Report
Monthly Report: New Drug Approvals in China | February 2024
SIGN UP
FOR OUR NEWSLETTER
to keep updated with China's pharma regulatory news and events
Subscribe
Name
*
Company
*
Email
*
Message
*
Cancel
Get in Touch Now